# NINTEDANIB
> **ANDA212732** · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE INC · Approved 2020-08-04
## Drug
- **FDA Application Number:** ANDA212732
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NINTEDANIB
- **Generic name:** Nintedanib
- **Active ingredients:** NINTEDANIB
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** ACCORD HLTHCARE INC
- **First approval:** 2020-08-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212732)
---
*AI Analytics · CC0 1.0*